US Patent Issued to Emory University, Children's Healthcare of Atlanta on March 17 for "Compositions and conjugates comprising an interleukin and polypeptides that specifically bind TGF-beta" (Georgia Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,323, issued on March 17, was assigned to Emory University (Atlanta) and Children's Healthcare of Atlanta Inc. (Atlanta).

"Compositions and conjugates comprising an interleukin and polypeptides that specifically bind TGF-beta" was invented by Jacques Galipeau (Atlanta) and Spencer Ng (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compositions and conjugates comprising an interleukin, e.g., IL-15 and a polypeptide that specifically binds TGF-beta. Typically the polypeptide that specifically binds TGF-beta is a type II TGF-beta receptor. In certain embodiments, the type II TGF-beta receptor is a human isoform, fragm...